I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 7 studies | 20% ± 4% | |
| memory B cell | 6 studies | 17% ± 1% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 5 studies | 17% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 21% ± 5% | |
| mucosal invariant T cell | 5 studies | 19% ± 3% | |
| naive B cell | 4 studies | 19% ± 2% | |
| natural killer cell | 4 studies | 20% ± 3% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| conventional dendritic cell | 3 studies | 25% ± 9% | |
| epithelial cell | 3 studies | 33% ± 6% | |
| fibroblast | 3 studies | 20% ± 4% | |
| endothelial cell | 3 studies | 21% ± 5% | |
| innate lymphoid cell | 3 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 32% ± 8% | |
| glutamatergic neuron | 3 studies | 47% ± 10% | |
| dendritic cell | 3 studies | 25% ± 5% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 6% |
